Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.

We previously identified protein hydrolysates from camel milk (CM) targeting dipeptidyl peptidase IV (DPP-IV) and insulin receptor (IR) activity. In this study, we synthesized nine peptides (P1 to P9) derived from such CM hydrolysates and profiled their potential bioactivity in vitro and in silico....

Full description

Saved in:
Bibliographic Details
Main Authors: Irfa Anwar, Farheen Badrealam Khan, Bincy Baby, Priya Antony, Priti Mudgil, Chee-Yuen Gan, Sajid Maqsood, Ranjit Vijayan, Khalid Muhammad, Mohammed Akli Ayoub
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0320812
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850261600723795968
author Irfa Anwar
Farheen Badrealam Khan
Bincy Baby
Priya Antony
Priti Mudgil
Chee-Yuen Gan
Sajid Maqsood
Ranjit Vijayan
Khalid Muhammad
Mohammed Akli Ayoub
author_facet Irfa Anwar
Farheen Badrealam Khan
Bincy Baby
Priya Antony
Priti Mudgil
Chee-Yuen Gan
Sajid Maqsood
Ranjit Vijayan
Khalid Muhammad
Mohammed Akli Ayoub
author_sort Irfa Anwar
collection DOAJ
description We previously identified protein hydrolysates from camel milk (CM) targeting dipeptidyl peptidase IV (DPP-IV) and insulin receptor (IR) activity. In this study, we synthesized nine peptides (P1 to P9) derived from such CM hydrolysates and profiled their potential bioactivity in vitro and in silico. This aims to validate and determine if such synthetic and pure CM-derived peptides are bioactive on IR function and glucose uptake using pharmacological and functional approaches in human embryonic kidney (HEK293) and human hepato-carcinoma (HepG2) cells. Our bioluminescence resonance energy transfer (BRET) results showed a partial activity of most peptides on IR activity in HEK293 cells ranging from 13 ± 1% to 65 ± 4%, and their potency varies from 3.13 ± 1.72 μg/ml to 12.30 ± 5.66 μg/ml. Combining the saturating dose (0.1 mg/ml) of peptides with insulin (1 μM) revealed three different profiles: non-efficient, potentiating, and antagonistic peptides. The potentiating effect of the peptides was from 104 ± 18% to 147 ± 11%, with one peptide (P2) reducing insulin's response to 52 ± 8%. Moreover, the peptides slightly promoted IR and AKT phosphorylation and glucose uptake in HepG2 cells with an efficacy of 56 ± 9% to 150 ± 18% on glucose transport. Our molecular docking study on the insulin-bound IR complex identified a potential allosteric binding site for specific bioactive peptides. Overall, our data confirmed the bioactivity of the synthetic CM-derived peptides on IR, AKT, and glucose uptake, consistent with the previous study on CM hydrolysates. The synthesis of the peptides and their validation provide further molecular insights into the antidiabetic action of CM. The study should pave the way for further in vitro and in vivo characterization of the peptides and developing potent and safe antidiabetic drugs based on the different CM-derived peptides described here.
format Article
id doaj-art-7d2173c2338f42648ea63644b66541cd
institution OA Journals
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-7d2173c2338f42648ea63644b66541cd2025-08-20T01:55:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01203e032081210.1371/journal.pone.0320812Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.Irfa AnwarFarheen Badrealam KhanBincy BabyPriya AntonyPriti MudgilChee-Yuen GanSajid MaqsoodRanjit VijayanKhalid MuhammadMohammed Akli AyoubWe previously identified protein hydrolysates from camel milk (CM) targeting dipeptidyl peptidase IV (DPP-IV) and insulin receptor (IR) activity. In this study, we synthesized nine peptides (P1 to P9) derived from such CM hydrolysates and profiled their potential bioactivity in vitro and in silico. This aims to validate and determine if such synthetic and pure CM-derived peptides are bioactive on IR function and glucose uptake using pharmacological and functional approaches in human embryonic kidney (HEK293) and human hepato-carcinoma (HepG2) cells. Our bioluminescence resonance energy transfer (BRET) results showed a partial activity of most peptides on IR activity in HEK293 cells ranging from 13 ± 1% to 65 ± 4%, and their potency varies from 3.13 ± 1.72 μg/ml to 12.30 ± 5.66 μg/ml. Combining the saturating dose (0.1 mg/ml) of peptides with insulin (1 μM) revealed three different profiles: non-efficient, potentiating, and antagonistic peptides. The potentiating effect of the peptides was from 104 ± 18% to 147 ± 11%, with one peptide (P2) reducing insulin's response to 52 ± 8%. Moreover, the peptides slightly promoted IR and AKT phosphorylation and glucose uptake in HepG2 cells with an efficacy of 56 ± 9% to 150 ± 18% on glucose transport. Our molecular docking study on the insulin-bound IR complex identified a potential allosteric binding site for specific bioactive peptides. Overall, our data confirmed the bioactivity of the synthetic CM-derived peptides on IR, AKT, and glucose uptake, consistent with the previous study on CM hydrolysates. The synthesis of the peptides and their validation provide further molecular insights into the antidiabetic action of CM. The study should pave the way for further in vitro and in vivo characterization of the peptides and developing potent and safe antidiabetic drugs based on the different CM-derived peptides described here.https://doi.org/10.1371/journal.pone.0320812
spellingShingle Irfa Anwar
Farheen Badrealam Khan
Bincy Baby
Priya Antony
Priti Mudgil
Chee-Yuen Gan
Sajid Maqsood
Ranjit Vijayan
Khalid Muhammad
Mohammed Akli Ayoub
Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.
PLoS ONE
title Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.
title_full Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.
title_fullStr Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.
title_full_unstemmed Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.
title_short Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes.
title_sort functional profiling of synthetic camel milk derived peptides with implication in glucose transport and diabetes
url https://doi.org/10.1371/journal.pone.0320812
work_keys_str_mv AT irfaanwar functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT farheenbadrealamkhan functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT bincybaby functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT priyaantony functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT pritimudgil functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT cheeyuengan functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT sajidmaqsood functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT ranjitvijayan functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT khalidmuhammad functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes
AT mohammedakliayoub functionalprofilingofsyntheticcamelmilkderivedpeptideswithimplicationinglucosetransportanddiabetes